Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SR1375 in hospitalized patients with pneumonia
ChiCTR2300067741Phase 2Recruiting
- Sponsor
- West China Hospital of Sichuan University
- Start
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of SR1375 in pneumonia, coronavirus pneumonia, community-acquired pneumonia (CAP) and 1 more (3 arms), sponsored by West China Hospital of Sichuan University. Primary endpoints: Vital signs, Physical examination and 11 more. Started Jan 2023; status: recruiting.
02
Drugs
SR1375
03
Conditions
pneumoniacoronavirus pneumoniacommunity-acquired pneumonia (CAP)hospital-acquired pneumonia (HAP)
Beyond the preview
Go deeper on ChiCTR2300067741.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300067741.